To identify and mitigate these risks prior to mass production, BOOMSTER integrates PFMEA (Process Failure Mode and Effects Analysis) during NPI and onboarding process. Rather than reacting after issues occur, we leverage scientific data and preventive mechanisms to control risks before they happen.

Case Background

In this project, an US medical device brand commissioned Boomster to develop high-precision medical-grade injection-molded components. Beyond strict requirements for dimensional accuracy and material compliance, the client prioritized "long-term quality stability" and "dependable lead times" as core metrics. To achieve this, Boomster controls manufacturing variables at the source and proactively prevents risks, ensuring consistent mass production quality while helping the client eliminate both explicit and implicit losses caused by the defects.

Case Focus: Two Critical Hidden Risks Most Important to Clients

Prior to mass production, the technical team focused on two critical failure risks:

1. Injection Molding Stability (Process Fluctuation Risk): Molding quality is influenced by factors such as material moisture content, melt viscosity, injection pressure, and packing conditions. Inadequate process management can cause weight or dimensional fluctuations, leading to short shots, flash, warpage, or assembly defects.
2. Long-Term Mold Wear (Mold Aging Risk): Molds endure up to hundreds of thousands of continuous cycles. As usage accumulates, cavity surface, parting lines, and sliding components can gradually wear down; once exceeding allowable thresholds, this may cause flash, loose fit, or damage to the mold itself.

Core Methodology: Systematically Assessing Risks and Setting Control Priorities via PFMEA

To tackle these challenges, BOOMSTER team gathered the members of mold design, injection process, and quality engineering to conduct PFMEA risk evaluations across each process step. Quantifying Severity (S), Occurrence (O), and Detection (D) on a scale of 1 to 10, the team calculated the Risk Priority Number (RPN):
RPN = Severity（S） × Occurrence（O） × Detection（D）
For high RPN factors, the team set early warning thresholds and prioritized countermeasures:

High RPN Factor A: Injection-Weight Fluctuation Leading to Dimensional or Cosmetic Defects

• Machine parameter drift or unstable melt conditions resulting in weight fluctuations, short shots, or flash within the same production batch.
• Risk Assessment: High Severity (impacts product function and safety, S=8), Moderate Occurrence (O=4), Moderate Detection (with visual inspection alone,weight variations are not easily detected in real time through visual inspection alone , D=5), RPN = 160 (classified as High Risk)

• BOOMSTER’s Countermeasures:

1. Establishing Scientific Molding Parameter Windows: Analyzing flows, packing curves, and weight trends to establish the optimal parameter window for stable mass production.
2. Implementing Automated Weight Measurement & Alert Systems: Utilizing high-precision digital scale for 100% inline weight monitoring. When injection weight strays from acceptance limits (e.g., +/-0.002g), the system alerts immediately and isolates non-conforming parts, reducing Detection from D=5 to D=1.

High RPN Factor B: LONG-TERM Mold Wear or Aging Leading to Flash and Dimensional Drift

• Potential Failure Mode: Long-term manufacturing cause wears on cavity surface, parting lines, or sliding structures, resulting in flash, dimensional drift, or assembly anomalies.
• Initial Risk Assessment: High Severity (affects cosmetics and assembly, S=7), High Occurrence (mold wear accumulates over usage cycles, O=6), Moderate Detection (D=4), RPN= 168 (classified as High Risk).

• BOOMSTER’s Countermeasures:
1. Upgrading Mold Steel & Surface Treatments: Selecting high-hardness, wear-resistant mold steel with excellent polishability (such as S136 or equivalent) for mold inserts, and evaluating surface coatings based on part needs to enhance wear resistance.
2. Establishing Preventive Maintenance (PM) Schedules: Defining periodic cleaning, inspection, and maintenance standards based on PFMEA wear risks and actual output; for example, inspecting parting lines and critical mating areas every 50,000 cycles, and replacing wearable components when necessary, reducing Occurrence from O=6 to O=2.

Implementation Results: Transforming Potential Risks into Predictable, Controllable Mass Production Conditions

Through upfront PFMEA assessment and countermeasure, BOOMSTER converted potential process risks into measurable, monitorable management metrics. Below is a quantitative comparison before and after PFMEA implementation:

Conclusion: Risk Prevention is Our Commitment to Medical Device Quality

In medical device manufacturing, quality should not just be the outcome of final inspection, but a preventive mechanism embedded across design, tooling, molding, and high-volume production. BOOMSTER believes that true manufacturing capability lies not just in solving problems quickly after they occur, but in controlling risks before they ever happen.
Through rigorous PFMEA, our team converts dynamic factors such as "injection molding stability" and "mold wear" into measurable, predictable, and continuously improvable process data. Partner with BOOMSTER to secure a resilient supply chain that seamlessly balances medical device quality requirements and long-term production stability.